Hepatic lipid-associated macrophages mediate the protective effects of bariatric surgery against NASH
Fredrickson, G.; Florczak, K.; Barrow, F.; Dietsche, K.; Parthiban, P.; Almutlaq, R.; Abujamra, M.; Demirchian, M.; Wang, H.; Nguyen, H.; Adeyi, O.; Bartolomucci, A.; Staley, C.; Jahansouz, C.; Williams, J. W.; Mashek, D.; Ikramuddin, S.; Revelo, X.
Show abstract
For patients with obesity and metabolic syndrome, bariatric procedures such as vertical sleeve gastrectomy (VSG) have a clear benefit in ameliorating metabolic dysfunction-associated steatohepatitis (MASH). While the effects of bariatric surgeries have been mainly attributed to nutrient restriction and malabsorption, whether immuno-modulatory mechanisms are involved remains unclear. Here we report that VSG ameliorates MASH progression in a weight loss- independent manner. Single-cell RNA sequencing revealed that hepatic lipid-associated macrophages (LAMs) expressing the triggering receptor expressed on myeloid cells 2 (TREM2) increase their lysosomal activity and repress inflammation in response to VSG. Remarkably, TREM2 deficiency in mice ablates the reparative effects of VSG, suggesting that TREM2 is required for MASH resolution. Mechanistically, TREM2 prevents the inflammatory activation of macrophages and is required for their efferocytotic function. Overall, our findings indicate that bariatric surgery improves MASH through a reparative process driven by hepatic LAMs, providing insights into the mechanisms of disease reversal that may result in new therapies and improved surgical interventions.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.